# Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

> **NCT06292117** · — · RECRUITING · sponsor: **University of Virginia** · enrollment: 350 (estimated)

## Conditions studied

- Ischemic Stroke
- CYP2C19 Polymorphism

## Interventions

- **OTHER:** CYP2C19 Genotype

## Key facts

- **NCT ID:** NCT06292117
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-16
- **Primary completion:** 2026-06
- **Final completion:** 2026-10
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06292117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06292117, "Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06292117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*